Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Cancer Cell|February 28, 2025
FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanomaSimone Lubrano, Rodolfo Daniel Cervantes-Villagrana, Farhoud Faraji, et al.
Pigment Cell & Melanoma Research|September 13, 2016
Melanoma central nervous system metastases: current approaches, challenges, and opportunitiesJustine V Cohen, Hussain Tawbi, Kim A Margolin, et al.
Cancer Cell|February 14, 2018
Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in MelanomaYong Yu, Kolja Schleich, Bin Yue, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Oxidative Phosphorylation (OXPHOS) Promotes the Formation and Growth of Melanoma Lung and Brain MetastasesRenato A Guerrieri, Grant M Fischer, David A Kircher, et al.
Cancer Discovery|December 15, 2020
Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell ImmunityAayoung Hong, Marco Piva, Sixue Liu, et al.
Cancer Research|July 10, 2020
Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell LinesManuel Valiente, Amanda E D Van Swearingen, Carey K Anders, et al.
Pigment Cell & Melanoma Research|February 4, 2019
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunitiesZeynep Eroglu, Sheri L Holmen, Qing Chen, et al.
Cancer Research|May 22, 2026
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated MelanomaMona Foth, Wontak Kim, Kayla O'Toole, et al.
Pigment Cell & Melanoma Research|August 1, 2022
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunitiesAlcida Karz, Maya Dimitrova, Kevin Kleffman, et al.
Cancer Cell|February 5, 2021
Melanoma models for the next generation of therapiesE Elizabeth Patton, Kristen L Mueller, David J Adams, et al.
Pageof 7